The aim of this study was to determine plasma levels of M-CSF, MMP-2 and TIMP-2 in comparison to CA 125 and SCC-Ag concentrations in patients with cervical cancer in relation to the control group (healthy subjects). The gene discussed is CSF1; the disease is cervical carcinoma.